{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:54:41Z","timestamp":1790934881800,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004077","name":"Kocaeli \u00dcniversitesi","doi-asserted-by":"publisher","award":["2874"],"award-info":[{"award-number":["2874"]}],"id":[{"id":"10.13039\/501100004077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06290-2","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:13:29Z","timestamp":1788502409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lack of association between the Dudley Inflammatory Bowel Symptom Questionnaire and fecal calprotectin in axial spondyloarthritis: a cross-sectional study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-050X","authenticated-orcid":false,"given":"Meryem","family":"Ozoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-493X","authenticated-orcid":false,"given":"Neslihan","family":"Gokcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-2032","authenticated-orcid":false,"given":"Duygu","family":"Temiz Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-3723","authenticated-orcid":false,"given":"Ozlem","family":"Ozdemir Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-7969","authenticated-orcid":false,"given":"Ayse","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-4509","authenticated-orcid":false,"given":"Ayten","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"10473","key":"6290_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0140-6736(24)02263-3","volume":"405","author":"V Navarro-Comp\u00e1n","year":"2025","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, Capelusnik D, Baraliakos X (2025) Axial spondyloarthritis. Lancet 405(10473):159\u2013172. https:\/\/doi.org\/10.1016\/S0140-6736(24)02263-3","journal-title":"Lancet"},{"key":"6290_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152890","volume":"76","author":"R Schotkosky","year":"2026","unstructured":"Schotkosky R, Dujardin T, Hup\u00e9 M, Baillet A, Romand X (2026) Self-administered screening questionnaires for spondyloarthritis in inflammatory bowel disease: A systematic review. Semin Arthritis Rheu 76:152890. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152890","journal-title":"Semin Arthritis Rheu"},{"issue":"Suppl 2","key":"6290_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/rheumatology\/xxvii.suppl_2.95","volume":"27","author":"H Mielants","year":"1988","unstructured":"Mielants H, Veys EM, Cuvelier C, de Vos M (1988) Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 27(Suppl 2):95\u2013105. https:\/\/doi.org\/10.1093\/rheumatology\/xxvii.suppl_2.95","journal-title":"Br J Rheumatol"},{"key":"6290_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/art.70095","author":"M Agrawal","year":"2026","unstructured":"Agrawal M, S\u00f8rensen CN, Poulsen GJ, Moghaddam B, Gulko PS, Colombel JF, Jess T (2026) Spondyloarthritis preceding and following \u0131nflammatory bowel disease diagnosis and risk factors: a temporal trends analysis in a population-based cohort. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.70095","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"6290_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13075-025-03663-z","volume":"27","author":"JK Wallman","year":"2025","unstructured":"Wallman JK, Mogard E, Sagard J, Andr\u00e9asson K, Marsal J, Inci F, Geijer M, Olofsson T, Lindqvist E (2025) Gut inflammation is associated with structural spinal damage in axial spondyloarthritis - results from the observational SPARTAKUS cohort. Arthritis Res Ther 27(1):195. https:\/\/doi.org\/10.1186\/s13075-025-03663-z","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"6290_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41584-023-00984-8","volume":"19","author":"G Cozzi","year":"2023","unstructured":"Cozzi G, Scagnellato L, Lorenzin M, Savarino E, Zingone F, Ometto F, Favero M, Doria A, Vavricka SR, Ramonda R (2023) Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nat Rev Rheumatol 19(8):503\u2013518. https:\/\/doi.org\/10.1038\/s41584-023-00984-8","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"6290_CR7","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1093\/rheumatology\/keaf420","volume":"64","author":"P Remalante-Rayco","year":"2025","unstructured":"Remalante-Rayco P, Daghistani Y, Chim T, Baskurt Z, Keshavarzi S, Passalent L, Poddubnyy D, Inman RD, Haroon N (2025) Inflammatory bowel disease does not confer higher disease activity or greater radiographic progression in axial spondyloarthritis. Rheumatology (Oxford) 64(12):6302\u20136308. https:\/\/doi.org\/10.1093\/rheumatology\/keaf420","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"6290_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-026-06108-1","volume":"46","author":"M Ozoglu","year":"2026","unstructured":"Ozoglu M, Temiz Karadag D, Gokcen N, Ozdemir Isik O, Yilmaz H, Cefle A, Yazici A (2026) Validation of the Dudley inflammatory bowel symptom questionnaire for assessing gastrointestinal symptom burden in axial spondyloarthritis. Rheumatol Int 46(4):76. https:\/\/doi.org\/10.1007\/s00296-026-06108-1","journal-title":"Rheumatol Int"},{"issue":"1","key":"6290_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00535-025-02301-4","volume":"61","author":"S Fukui","year":"2026","unstructured":"Fukui S, Kishimoto M, Matsuura M, Sakamoto A, Ono K, Kobayashi S, Kawashima S, Ikegaya N, Kawakami T, Mitsui T, Saito D, Hayashida M, Miyoshi J, Komagata Y, Hisamatsu T (2026) Prevalence, characteristics, and screening of spondyloarthritis in Japanese patients with early inflammatory bowel diseases: a prospective multidisciplinary study. J Gastroenterol 61(1):46\u201358. https:\/\/doi.org\/10.1007\/s00535-025-02301-4","journal-title":"J Gastroenterol"},{"issue":"1","key":"6290_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-025-01181-0","volume":"27","author":"R Jan","year":"2025","unstructured":"Jan R, Hong SJ, Ermann J (2025) Screening for spondyloarthritis in patients with inflammatory bowel disease - SPARTAN 2024 annual meeting proceedings. Curr Rheumatol Rep 27(1):17. https:\/\/doi.org\/10.1007\/s11926-025-01181-0","journal-title":"Curr Rheumatol Rep"},{"key":"6290_CR11","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5088","volume":"6","author":"RL Roberts","year":"2018","unstructured":"Roberts RL, Wallace MC, Harrison AA, White D, Dalbeth N, Stamp LK, Ching D, Highton J, Merriman TR, Robinson PC, Brown MA, Stebbings SM (2018) Association of Crohn\u2019s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin. PeerJ 6:e5088. https:\/\/doi.org\/10.7717\/peerj.5088","journal-title":"PeerJ"},{"issue":"5","key":"6290_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/rheumatology\/ker359","volume":"51","author":"S Stebbings","year":"2012","unstructured":"Stebbings S, Jenks K, Treharne GJ, Garc\u00eda JA, Schultz M, Highton J, Dudley-Brown S (2012) Validation of the Dudley inflammatory bowel symptom questionnaire for the assessment of bowel symptoms in axial SpA: prevalence of clinically relevant bowel symptoms and association with disease activity. Rheumatology (Oxford) 51(5):858\u2013865. https:\/\/doi.org\/10.1093\/rheumatology\/ker359","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"6290_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007306","volume":"5","author":"S Hasler","year":"2015","unstructured":"Hasler S, Zahnd N, M\u00fcller S, Vavricka S, Rogler G, Tandjung R, Rosemann T (2015) Validation of an 8-item-questionnaire predictive for a positive calprotectin test and real-life implementation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study. BMJ Open 5(3):e007306. https:\/\/doi.org\/10.1136\/bmjopen-2014-007306","journal-title":"BMJ Open"},{"issue":"5","key":"6290_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/ecco-jcc\/jjz205","volume":"14","author":"M Fauny","year":"2020","unstructured":"Fauny M, D\u2019Amico F, Bonovas S, Netter P, Danese S, Loeuille D, Peyrin-Biroulet L (2020) Faecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review. J Crohns Colitis 14(5):688\u2013693. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz205","journal-title":"J Crohns Colitis"},{"issue":"10","key":"6290_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"issue":"6","key":"6290_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S\u00f8rensen IJ, Ozgocmen S, Roussou E, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233. (Erratum in: Ann Rheum Dis. 2019 Jun;78(6):e59. 10.1136\/ard.2009.108233corr1)","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6290_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10067-004-0984-6","volume":"24","author":"HT Ozer","year":"2005","unstructured":"Ozer HT, Sarpel T, Gulek B, Alparslan ZN, Erken E (2005) The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24(2):123\u2013128. https:\/\/doi.org\/10.1007\/s10067-004-0984-6","journal-title":"Clin Rheumatol"},{"issue":"4","key":"6290_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00296-003-0432-y","volume":"25","author":"Y Akkoc","year":"2005","unstructured":"Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280\u2013284. https:\/\/doi.org\/10.1007\/s00296-003-0432-y","journal-title":"Rheumatol Int"},{"key":"6290_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1477-7525-9-36","volume":"9","author":"DA Revicki","year":"2011","unstructured":"Revicki DA, Rentz AM, Luo MP, Wong RL (2011) Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness therapy-fatigue subscale for patients with ankylosing spondylitis. Health Qual Life Outcomes 9:36. https:\/\/doi.org\/10.1186\/1477-7525-9-36","journal-title":"Health Qual Life Outcomes"},{"key":"6290_CR20","unstructured":"Dudley SL (1994) Correlates of uncertainty in inflammatory bowel disease. [Online]. Available: https:\/\/archive.hshsl.umaryland.edu\/handle\/10713\/1503. Accessed 17 Jan 2025"},{"issue":"11","key":"6290_CR21","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.purol.2014.06.008","volume":"24","author":"G Amarenco","year":"2014","unstructured":"Amarenco G (2014) Bristol Stool Chart: \u00e9tude prospective et monocentrique de \u00ab\u00a0l\u2019introspection f\u00e9cale\u00a0\u00bb chez des sujets volontaires [Bristol Stool Chart: Prospective and monocentric study of \u201cstools introspection\u201d in healthy subjects]. Prog Urol 24(11):708\u2013713. https:\/\/doi.org\/10.1016\/j.purol.2014.06.008. (French)","journal-title":"Prog Urol"},{"issue":"5","key":"6290_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5009\/gnl210393","volume":"15","author":"ES Kim","year":"2021","unstructured":"Kim ES (2021) Optimal cutoff level of fecal calprotectin for detecting small bowel inflammation in Crohn\u2019s disease. Gut Liver 15(5):637\u2013638. https:\/\/doi.org\/10.5009\/gnl210393","journal-title":"Gut Liver"},{"issue":"1","key":"6290_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-04494-7","volume":"26","author":"C Tack","year":"2025","unstructured":"Tack C, Van den Houte K, Besard L, Capiau L, Ceulemans S, Gernay O, Maes S, Peetermans C, Raat W, Stubbe J, Van Boxstael R, Vandeput O, Van Steenbergen S, Gehesqui\u00e8re B, Raes J, Tack J, Carbone F (2025) A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial. BMC Gastroenterol 26(1):69. https:\/\/doi.org\/10.1186\/s12876-025-04494-7","journal-title":"BMC Gastroenterol"},{"key":"6290_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394148","volume":"15","author":"D Liu","year":"2024","unstructured":"Liu D, Xie Y, Tu L, Wen X, Lv Q, Liu B, Yang M, Wu X, Zheng X, Luo X, Zhou L, Wu J, Liu B, Wang K, Jin O, Wang X, Qin J, Wu L, Zhao D, He D, He S, Huang W, Ye S, Zhou H, Wu J, Wang Y, Liu S, Li Z, Tan Z, Xu C, Wang Y, Zheng D, Zhan F, Lin C, Wen Y, Wu J, Wen S, Liao Z, Shen Y, Yang K, Gu J (2024) A guideline on biomarkers in the diagnosis and evaluation in axial spondyloarthritis. Front Immunol 15:1394148. https:\/\/doi.org\/10.3389\/fimmu.2024.1394148","journal-title":"Front Immunol"},{"key":"6290_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ero.2026.100206","author":"C Morizot","year":"2026","unstructured":"Morizot C, Caron B, Jouzeau JY et al (2026) Faecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatologic diseases: what is new in the last 5 years (2020-2025)? EULAR Rheumatol Open. https:\/\/doi.org\/10.1016\/j.ero.2026.100206","journal-title":"EULAR Rheumatol Open"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06290-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06290-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06290-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:10:03Z","timestamp":1790932203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06290-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6290"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06290-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Non-Interventional Clinical Research Ethics Committee of Kocaeli University (approval number: KU GOKAEK-2021\/20.13; approval date: November 18, 2021). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Ethical approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used OpenAI ChatGPT solely to improve the language, grammar, and readability of the manuscript. The draft was critically reviewed, revised where necessary, and verified for accuracy by the authors. The authors take full responsibility for the content of the manuscript, including its accuracy, integrity, and scientific conclusions.","order":3,"name":"Ethics","label":"Artificial intelligence disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is original, has not been published previously, and is not under consideration elsewhere. No scientific content, including the study design, data analysis, interpretation, or conclusions, was generated by artificial intelligence. OpenAI ChatGPT was used solely for language editing.","order":4,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"251"}}